APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liganlong Granules

Compare research editions
View pricing & licenses

Selected research

Industry Research

Liganlong Granules Industry Research Report 2026

28 December 2025151 pages

Choose your research edition.

Industry ResearchLiganlong Granules Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Liganlong Granules Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Liganlong Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liganlong Granules Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Liganlong Granules Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Liganlong Granules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Liganlong Granules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Liganlong Granules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Liganlong Granules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Liganlong Granules include Zhongjing Wanxi Pharmaceutical Co., Ltd., Tibet Tibetan Medicine Group Co., Ltd., Sichuan Luye Pharmaceutical Co., Ltd., Liaoning Wohua Kangchen Pharmaceutical Co., Ltd., Liaoning Keji Pharmaceutical Co., Ltd., Liaoning Dongyi Pharmaceutical Co., Ltd., Jiangxi Chuanqi Pharmaceutical Co., Ltd., Jilin Yatai Pharmaceutical Co., Ltd. and Jilin Yinoke Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Liganlong Granules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Liganlong Granules Market by Company

Zhongjing Wanxi Pharmaceutical Co., Ltd.

Tibet Tibetan Medicine Group Co., Ltd.

Sichuan Luye Pharmaceutical Co., Ltd.

Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.

Liaoning Keji Pharmaceutical Co., Ltd.

Liaoning Dongyi Pharmaceutical Co., Ltd.

Jiangxi Chuanqi Pharmaceutical Co., Ltd.

Jilin Yatai Pharmaceutical Co., Ltd.

Jilin Yinoke Pharmaceutical Co., Ltd.

Jilin Aodong Yanbian Pharmaceutical Co., Ltd.

Heilongjiang Tianhong Pharmaceutical Co., Ltd.

Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.

Hainan Zhongbao Pharmaceutical Co., Ltd.

Sinopharm Group Yibin Pharmaceutical Co., Ltd.

Guizhou Dalong Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.

Guangxi Xiuzhen Pharmaceutical Co., Ltd.

Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.

Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.

Dalian Meiluo Chinese Medicine Factory Co., Ltd.

Dalian Hanfang Pharmaceutical Co., Ltd.

Liganlong Granules Segment by Type

5g

10g

Liganlong Granules Segment by Application

Hospital

Clinic

Other

Liganlong Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liganlong Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liganlong Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liganlong Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Liganlong Granules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Liganlong Granules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Liganlong Granules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Liganlong Granules Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Liganlong Granules Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Liganlong Granules Sales Market Share by Manufacturers (2021-2026) Table 8. Global Liganlong Granules Revenue of Manufacturers (2021-2026) Table 9. Global Liganlong Granules Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Liganlong Granules Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Liganlong Granules Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Liganlong Granules, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Liganlong Granules, Product Type & Application Table 14. Global Liganlong Granules Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Liganlong Granules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information Table 19. Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview Table 20. Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 22. Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Developments Table 23. Tibet Tibetan Medicine Group Co., Ltd. Company Information Table 24. Tibet Tibetan Medicine Group Co., Ltd. Business Overview Table 25. Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Product Portfolio Table 27. Tibet Tibetan Medicine Group Co., Ltd. Recent Developments Table 28. Sichuan Luye Pharmaceutical Co., Ltd. Company Information Table 29. Sichuan Luye Pharmaceutical Co., Ltd. Business Overview Table 30. Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 32. Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments Table 33. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Company Information Table 34. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Business Overview Table 35. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 37. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Recent Developments Table 38. Liaoning Keji Pharmaceutical Co., Ltd. Company Information Table 39. Liaoning Keji Pharmaceutical Co., Ltd. Business Overview Table 40. Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 42. Liaoning Keji Pharmaceutical Co., Ltd. Recent Developments Table 43. Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information Table 44. Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview Table 45. Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 47. Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Developments Table 48. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Company Information Table 49. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Business Overview Table 50. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 52. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Recent Developments Table 53. Jilin Yatai Pharmaceutical Co., Ltd. Company Information Table 54. Jilin Yatai Pharmaceutical Co., Ltd. Business Overview Table 55. Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 57. Jilin Yatai Pharmaceutical Co., Ltd. Recent Developments Table 58. Jilin Yinoke Pharmaceutical Co., Ltd. Company Information Table 59. Jilin Yinoke Pharmaceutical Co., Ltd. Business Overview Table 60. Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 62. Jilin Yinoke Pharmaceutical Co., Ltd. Recent Developments Table 63. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information Table 64. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview Table 65. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 67. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Developments Table 68. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information Table 69. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview Table 70. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 72. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Developments Table 73. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Company Information Table 74. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Business Overview Table 75. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 77. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Recent Developments Table 78. Hainan Zhongbao Pharmaceutical Co., Ltd. Company Information Table 79. Hainan Zhongbao Pharmaceutical Co., Ltd. Business Overview Table 80. Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 82. Hainan Zhongbao Pharmaceutical Co., Ltd. Recent Developments Table 83. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information Table 84. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview Table 85. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 87. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments Table 88. Guizhou Dalong Pharmaceutical Co., Ltd. Company Information Table 89. Guizhou Dalong Pharmaceutical Co., Ltd. Business Overview Table 90. Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 92. Guizhou Dalong Pharmaceutical Co., Ltd. Recent Developments Table 93. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information Table 94. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview Table 95. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 97. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments Table 98. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Company Information Table 99. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Business Overview Table 100. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 102. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Recent Developments Table 103. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Company Information Table 104. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Business Overview Table 105. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 107. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Recent Developments Table 108. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Company Information Table 109. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Business Overview Table 110. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Product Portfolio Table 112. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Recent Developments Table 113. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Company Information Table 114. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Business Overview Table 115. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Product Portfolio Table 117. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Recent Developments Table 118. Dalian Hanfang Pharmaceutical Co., Ltd. Company Information Table 119. Dalian Hanfang Pharmaceutical Co., Ltd. Business Overview Table 120. Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 122. Dalian Hanfang Pharmaceutical Co., Ltd. Recent Developments Table 123. Global Liganlong Granules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 124. Global Liganlong Granules Sales by Region (2021-2026) & (K Units) Table 125. Global Liganlong Granules Sales Market Share by Region (2021-2026) Table 126. Global Liganlong Granules Sales by Region (2027-2032) & (K Units) Table 127. Global Liganlong Granules Sales Market Share by Region (2027-2032) Table 128. Global Liganlong Granules Revenue by Region (2021-2026) & (US$ Million) Table 129. Global Liganlong Granules Revenue Market Share by Region (2021-2026) Table 130. Global Liganlong Granules Revenue by Region (2027-2032) & (US$ Million) Table 131. Global Liganlong Granules Revenue Market Share by Region (2027-2032) Table 132. North America Liganlong Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. North America Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 134. North America Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 135. North America Liganlong Granules Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Liganlong Granules Revenue by Country (2027-2032) & (US$ Million) Table 137. Europe Liganlong Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Europe Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 139. Europe Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 140. Europe Liganlong Granules Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Liganlong Granules Revenue by Country (2027-2032) & (US$ Million) Table 142. Asia Pacific Liganlong Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Asia Pacific Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 144. Asia Pacific Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 145. Asia Pacific Liganlong Granules Revenue by Country (2021-2026) & (US$ Million) Table 146. Asia Pacific Liganlong Granules Revenue by Country (2027-2032) & (US$ Million) Table 147. South America Liganlong Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. South America Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 149. South America Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 150. South America Liganlong Granules Revenue by Country (2021-2026) & (US$ Million) Table 151. South America Liganlong Granules Revenue by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Liganlong Granules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Middle East and Africa Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Liganlong Granules Revenue by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Liganlong Granules Revenue by Country (2027-2032) & (US$ Million) Table 157. Global Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 158. Global Liganlong Granules Sales by Type (2027-2032) & (K Units) Table 159. Global Liganlong Granules Sales Market Share by Type (2021-2026) Table 160. Global Liganlong Granules Sales Market Share by Type (2027-2032) Table 161. Global Liganlong Granules Revenue by Type (2021-2026) & (US$ Million) Table 162. Global Liganlong Granules Revenue by Type (2027-2032) & (US$ Million) Table 163. Global Liganlong Granules Revenue Market Share by Type (2021-2026) Table 164. Global Liganlong Granules Revenue Market Share by Type (2027-2032) Table 165. Global Liganlong Granules Price by Type (2021-2026) & (US$/Unit) Table 166. Global Liganlong Granules Price by Type (2027-2032) & (US$/Unit) Table 167. Global Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 168. Global Liganlong Granules Sales by Application (2027-2032) & (K Units) Table 169. Global Liganlong Granules Sales Market Share by Application (2021-2026) Table 170. Global Liganlong Granules Sales Market Share by Application (2027-2032) Table 171. Global Liganlong Granules Revenue by Application (2021-2026) & (US$ Million) Table 172. Global Liganlong Granules Revenue by Application (2027-2032) & (US$ Million) Table 173. Global Liganlong Granules Revenue Market Share by Application (2021-2026) Table 174. Global Liganlong Granules Revenue Market Share by Application (2027-2032) Table 175. Global Liganlong Granules Price by Application (2021-2026) & (US$/Unit) Table 176. Global Liganlong Granules Price by Application (2027-2032) & (US$/Unit) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Liganlong Granules Distributors List Table 180. Liganlong Granules Customers List Table 181. Liganlong Granules Industry Trends Table 182. Liganlong Granules Industry Drivers Table 183. Liganlong Granules Industry Restraints Table 184. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Liganlong Granules Product Image Figure 5. Global Liganlong Granules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Liganlong Granules Market Size (2021-2032) & (US$ Million) Figure 7. Global Liganlong Granules Sales (2021-2032) & (K Units) Figure 8. Global Liganlong Granules Average Price (US$/Unit) & (2021-2032) Figure 9. 5g Product Image Figure 10. 10g Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Liganlong Granules Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Liganlong Granules, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Liganlong Granules Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Liganlong Granules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Liganlong Granules Sales by Region in 2025 Figure 20. Global Liganlong Granules Revenue by Region in 2025 Figure 21. North America Liganlong Granules Market Size by Country in 2025 Figure 22. North America Liganlong Granules Sales Market Share by Country (2021-2032) Figure 23. North America Liganlong Granules Revenue Market Share by Country (2021-2032) Figure 24. United States Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Liganlong Granules Market Size by Country in 2025 Figure 28. Europe Liganlong Granules Sales Market Share by Country (2021-2032) Figure 29. Europe Liganlong Granules Revenue Market Share by Country (2021-2032) Figure 30. Germany Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Liganlong Granules Market Size by Country in 2025 Figure 41. Asia Pacific Liganlong Granules Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Liganlong Granules Revenue Market Share by Country (2021-2032) Figure 43. China Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Liganlong Granules Market Size by Country in 2025 Figure 52. South America Liganlong Granules Sales Market Share by Country (2021-2032) Figure 53. South America Liganlong Granules Revenue Market Share by Country (2021-2032) Figure 54. Brazil Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Liganlong Granules Market Size by Country in 2025 Figure 58. Middle East and Africa Liganlong Granules Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Liganlong Granules Revenue Market Share by Country (2021-2032) Figure 60. Egypt Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Liganlong Granules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Liganlong Granules Sales Market Share by Type (2021-2032) Figure 66. Global Liganlong Granules Revenue Market Share by Type (2021-2032) Figure 67. Global Liganlong Granules Price (US$/Unit) by Type (2021-2032) Figure 68. Global Liganlong Granules Sales Market Share by Application (2021-2032) Figure 69. Global Liganlong Granules Revenue Market Share by Application (2021-2032) Figure 70. Global Liganlong Granules Price (US$/Unit) by Application (2021-2032) Figure 71. Liganlong Granules Value Chain Figure 72. Liganlong Granules Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Liganlong Granules Industry Opportunities and Challenges

Scope & coverage.

Types
  • 5g
  • 10g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Zhongjing Wanxi Pharmaceutical Co., Ltd.
  • Tibet Tibetan Medicine Group Co., Ltd.
  • Sichuan Luye Pharmaceutical Co., Ltd.
  • Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.
  • Liaoning Keji Pharmaceutical Co., Ltd.
  • Liaoning Dongyi Pharmaceutical Co., Ltd.
  • Jiangxi Chuanqi Pharmaceutical Co., Ltd.
  • Jilin Yatai Pharmaceutical Co., Ltd.
  • Jilin Yinoke Pharmaceutical Co., Ltd.
  • Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  • Heilongjiang Tianhong Pharmaceutical Co., Ltd.
  • Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.
  • Hainan Zhongbao Pharmaceutical Co., Ltd.
  • Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  • Guizhou Dalong Pharmaceutical Co., Ltd.
  • Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  • Guangxi Xiuzhen Pharmaceutical Co., Ltd.
  • Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.
  • Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.
  • Dalian Meiluo Chinese Medicine Factory Co., Ltd.
  • Dalian Hanfang Pharmaceutical Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Liganlong Granules Market Size (2021-2032)
  4. 2.2.2 Global Liganlong Granules Sales (2021-2032)
  5. 2.2.3 Global Liganlong Granules Market Average Price (2021-2032)
  6. 2.3 Liganlong Granules by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 5g
  9. 2.3.3 10g
  10. 2.4 Liganlong Granules by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Liganlong Granules Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Liganlong Granules Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Liganlong Granules Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Liganlong Granules Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Liganlong Granules Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Liganlong Granules, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Liganlong Granules, Product Type & Application
  8. 3.8 Global Manufacturers of Liganlong Granules, Established Date
  9. 3.9 Global Liganlong Granules Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhongjing Wanxi Pharmaceutical Co., Ltd.
  2. 4.1.1 Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  6. 4.1.5 Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Tibet Tibetan Medicine Group Co., Ltd.
  8. 4.2.1 Tibet Tibetan Medicine Group Co., Ltd. Company Information
  9. 4.2.2 Tibet Tibetan Medicine Group Co., Ltd. Business Overview
  10. 4.2.3 Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Product Portfolio
  12. 4.2.5 Tibet Tibetan Medicine Group Co., Ltd. Recent Developments
  13. 4.3 Sichuan Luye Pharmaceutical Co., Ltd.
  14. 4.3.1 Sichuan Luye Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Sichuan Luye Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  18. 4.3.5 Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.
  20. 4.4.1 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Company Information
  21. 4.4.2 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Business Overview
  22. 4.4.3 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  24. 4.4.5 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Recent Developments
  25. 4.5 Liaoning Keji Pharmaceutical Co., Ltd.
  26. 4.5.1 Liaoning Keji Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Liaoning Keji Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  30. 4.5.5 Liaoning Keji Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Liaoning Dongyi Pharmaceutical Co., Ltd.
  32. 4.6.1 Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  36. 4.6.5 Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Jiangxi Chuanqi Pharmaceutical Co., Ltd.
  38. 4.7.1 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  42. 4.7.5 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Jilin Yatai Pharmaceutical Co., Ltd.
  44. 4.8.1 Jilin Yatai Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Jilin Yatai Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  48. 4.8.5 Jilin Yatai Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Jilin Yinoke Pharmaceutical Co., Ltd.
  50. 4.9.1 Jilin Yinoke Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Jilin Yinoke Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  54. 4.9.5 Jilin Yinoke Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  56. 4.10.1 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information
  57. 4.10.2 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview
  58. 4.10.3 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  60. 4.10.5 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Developments
  61. 4.11 Heilongjiang Tianhong Pharmaceutical Co., Ltd.
  62. 4.11.1 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  66. 4.11.5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.
  68. 4.12.1 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  72. 4.12.5 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Hainan Zhongbao Pharmaceutical Co., Ltd.
  74. 4.13.1 Hainan Zhongbao Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Hainan Zhongbao Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  78. 4.13.5 Hainan Zhongbao Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  80. 4.14.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
  81. 4.14.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview
  82. 4.14.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  84. 4.14.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments
  85. 4.15 Guizhou Dalong Pharmaceutical Co., Ltd.
  86. 4.15.1 Guizhou Dalong Pharmaceutical Co., Ltd. Company Information
  87. 4.15.2 Guizhou Dalong Pharmaceutical Co., Ltd. Business Overview
  88. 4.15.3 Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  90. 4.15.5 Guizhou Dalong Pharmaceutical Co., Ltd. Recent Developments
  91. 4.16 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  92. 4.16.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information
  93. 4.16.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
  94. 4.16.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  96. 4.16.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
  97. 4.17 Guangxi Xiuzhen Pharmaceutical Co., Ltd.
  98. 4.17.1 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Company Information
  99. 4.17.2 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Business Overview
  100. 4.17.3 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  102. 4.17.5 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Recent Developments
  103. 4.18 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.
  104. 4.18.1 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Company Information
  105. 4.18.2 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Business Overview
  106. 4.18.3 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  108. 4.18.5 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Recent Developments
  109. 4.19 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.
  110. 4.19.1 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Company Information
  111. 4.19.2 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Business Overview
  112. 4.19.3 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Product Portfolio
  114. 4.19.5 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Recent Developments
  115. 4.20 Dalian Meiluo Chinese Medicine Factory Co., Ltd.
  116. 4.20.1 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Company Information
  117. 4.20.2 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Business Overview
  118. 4.20.3 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Product Portfolio
  120. 4.20.5 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Recent Developments
  121. 4.21 Dalian Hanfang Pharmaceutical Co., Ltd.
  122. 4.21.1 Dalian Hanfang Pharmaceutical Co., Ltd. Company Information
  123. 4.21.2 Dalian Hanfang Pharmaceutical Co., Ltd. Business Overview
  124. 4.21.3 Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  126. 4.21.5 Dalian Hanfang Pharmaceutical Co., Ltd. Recent Developments
5 Global Liganlong Granules Market Scenario by Region
  1. 5.1 Global Liganlong Granules Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Liganlong Granules Sales by Region: 2021-2032
  3. 5.2.1 Global Liganlong Granules Sales by Region: 2021-2026
  4. 5.2.2 Global Liganlong Granules Sales by Region: 2027-2032
  5. 5.3 Global Liganlong Granules Revenue by Region: 2021-2032
  6. 5.3.1 Global Liganlong Granules Revenue by Region: 2021-2026
  7. 5.3.2 Global Liganlong Granules Revenue by Region: 2027-2032
  8. 5.4 North America Liganlong Granules Market Facts & Figures by Country
  9. 5.4.1 North America Liganlong Granules Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Liganlong Granules Sales by Country (2021-2032)
  11. 5.4.3 North America Liganlong Granules Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Liganlong Granules Market Facts & Figures by Country
  16. 5.5.1 Europe Liganlong Granules Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Liganlong Granules Sales by Country (2021-2032)
  18. 5.5.3 Europe Liganlong Granules Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Liganlong Granules Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Liganlong Granules Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Liganlong Granules Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Liganlong Granules Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Liganlong Granules Market Facts & Figures by Country
  41. 5.7.1 South America Liganlong Granules Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Liganlong Granules Sales by Country (2021-2032)
  43. 5.7.3 South America Liganlong Granules Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Liganlong Granules Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Liganlong Granules Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Liganlong Granules Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Liganlong Granules Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Liganlong Granules Sales by Type (2021-2032)
  2. 6.1.1 Global Liganlong Granules Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Liganlong Granules Sales Market Share by Type (2021-2032)
  4. 6.2 Global Liganlong Granules Revenue by Type (2021-2032)
  5. 6.2.1 Global Liganlong Granules Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Liganlong Granules Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Liganlong Granules Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Liganlong Granules Sales by Application (2021-2032)
  2. 7.1.1 Global Liganlong Granules Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Liganlong Granules Sales Market Share by Application (2021-2032)
  4. 7.2 Global Liganlong Granules Revenue by Application (2021-2032)
  5. 7.2.1 Global Liganlong Granules Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Liganlong Granules Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Liganlong Granules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Liganlong Granules Value Chain Analysis
  2. 8.1.1 Liganlong Granules Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Liganlong Granules Production Mode & Process
  5. 8.2 Liganlong Granules Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Liganlong Granules Distributors
  8. 8.2.3 Liganlong Granules Customers
9 Global Liganlong Granules Analyzing Market Dynamics
  1. 9.1 Liganlong Granules Industry Trends
  2. 9.2 Liganlong Granules Industry Drivers
  3. 9.3 Liganlong Granules Industry Opportunities and Challenges
  4. 9.4 Liganlong Granules Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst